Givaudan SA (OTCMKTS:GVDNY - Get Free Report) was the recipient of a significant increase in short interest in the month of September. As of September 30th, there was short interest totaling 5,600 shares, an increase of 522.2% from the September 15th total of 900 shares. Based on an average daily trading volume, of 113,400 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily trading volume, of 113,400 shares, the days-to-cover ratio is presently 0.0 days.
Wall Street Analysts Forecast Growth
GVDNY has been the topic of a number of recent research reports. Barclays upgraded Givaudan from a "strong sell" rating to a "hold" rating in a report on Tuesday, July 8th. Jefferies Financial Group upgraded Givaudan from a "moderate sell" rating to a "hold" rating in a report on Friday, September 12th. One research analyst has rated the stock with a Strong Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy".
View Our Latest Analysis on GVDNY
Givaudan Stock Performance
Shares of Givaudan stock traded up $0.84 during trading hours on Friday, hitting $89.82. 33,779 shares of the company's stock traded hands, compared to its average volume of 38,497. Givaudan has a 12-month low of $79.46 and a 12-month high of $103.39. The company has a fifty day simple moving average of $83.93 and a 200-day simple moving average of $90.94. The company has a current ratio of 1.38, a quick ratio of 0.85 and a debt-to-equity ratio of 0.91.
Givaudan Company Profile
(
Get Free Report)
Givaudan SA manufactures, supplies, and sells fragrance, beauty, taste, and wellbeing products to the consumer goods industry. The company operates through divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Givaudan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Givaudan wasn't on the list.
While Givaudan currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.